Clinical Trial Update: Treatment of Chronic Granulomatous Disease With Allogeneic Stem Cell Transplantation Versus Standard of Care [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing allogeneic stem cell transplantation to standard of care in chronic granulomatous disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatous Disease

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Chronic Granulomatous Disease | Phase 3 | Status: COMPLETED